When XDx yesterday filed to raise up to $86.3 million in an IPO, the Brisbane, Calif., company joined just a handful of similar molecular-diagnostic companies to test the public markets. XDx ...

BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, today announced the ...

PARIS & BRISBANE, Calif.--(BUSINESS WIRE)--Regulatory News: Diaxonhit (Paris:ALEHT), the leading French provider of specialty diagnostic solutions, and XDx, Inc., a U.S. molecular diagnostics company ...

BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company that discovers, develops and commercializes high value, non-invasive tests to monitor immune status in transplant ...

Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced a $15 million round of debt financing for XDx, Inc ...

BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, announced today that it has ...

MISSISSAUGA, ONTARIO and BRISBANE, CALIFORNIA--(Marketwired - Jun 20, 2013) - CML HealthCare Inc. (CLC.TO) (the "Company" or "CML HealthCare"), a leading provider of medical diagnostic services in ...

BRISBANE, Calif.--(BUSINESS WIRE)-- XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive gene expression ...

XenDex is the first fully integrated, all-in-one decentralized exchange (DEX) developed natively on the XRP Ledger. It brings fast, secure, and low-cost DeFi features together in one sleek interface, ...